JP2005525371A5 - - Google Patents

Download PDF

Info

Publication number
JP2005525371A5
JP2005525371A5 JP2003574134A JP2003574134A JP2005525371A5 JP 2005525371 A5 JP2005525371 A5 JP 2005525371A5 JP 2003574134 A JP2003574134 A JP 2003574134A JP 2003574134 A JP2003574134 A JP 2003574134A JP 2005525371 A5 JP2005525371 A5 JP 2005525371A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
compound
amino
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003574134A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005525371A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/007240 external-priority patent/WO2003075858A2/en
Publication of JP2005525371A publication Critical patent/JP2005525371A/ja
Publication of JP2005525371A5 publication Critical patent/JP2005525371A5/ja
Pending legal-status Critical Current

Links

JP2003574134A 2002-03-08 2003-03-07 糖尿病および他の疾患を治療するための二環式複素環 Pending JP2005525371A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36273202P 2002-03-08 2002-03-08
PCT/US2003/007240 WO2003075858A2 (en) 2002-03-08 2003-03-07 Bicyclic heterocycles for the treatment of diabetes and other diseases

Publications (2)

Publication Number Publication Date
JP2005525371A JP2005525371A (ja) 2005-08-25
JP2005525371A5 true JP2005525371A5 (cg-RX-API-DMAC7.html) 2006-03-23

Family

ID=27805219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003574134A Pending JP2005525371A (ja) 2002-03-08 2003-03-07 糖尿病および他の疾患を治療するための二環式複素環

Country Status (9)

Country Link
US (1) US7196108B2 (cg-RX-API-DMAC7.html)
EP (1) EP1487446A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005525371A (cg-RX-API-DMAC7.html)
AU (1) AU2003223233A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308278A (cg-RX-API-DMAC7.html)
CA (1) CA2478765A1 (cg-RX-API-DMAC7.html)
IL (1) IL163953A0 (cg-RX-API-DMAC7.html)
TW (1) TWI277415B (cg-RX-API-DMAC7.html)
WO (1) WO2003075858A2 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1384825A (zh) * 1999-08-31 2002-12-11 马克西亚药品公司 亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用
BR0207846A (pt) * 2001-03-07 2005-09-13 Incyte San Diego Inc Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas
JP2004523571A (ja) * 2001-03-08 2004-08-05 マキシア・ファーマシューティカルズ・インコーポレイテッド Rxr活性化分子
EP1421061A4 (en) * 2001-08-17 2004-12-22 Incyte San Diego Inc OXIME DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA AND HYPERCHOLESTEROLEMIA
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US7196108B2 (en) 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
ATE540047T1 (de) * 2002-06-25 2012-01-15 Helicon Therapeutics Inc Gedächtnisveränderung durch beeinflussung der funktion von staufen
PT1572215E (pt) 2002-12-20 2009-12-09 Glaxo Group Ltd Derivados de benzo[d]azepina para o tratamento de perturbações neurológicas
BRPI0409501A (pt) * 2003-04-18 2006-04-18 Incyte San Diego Inc compostos isocromanos substituìdos para o tratamento de desordens metabólicas, de cáncer e de outras doenças
US7122700B2 (en) 2004-07-30 2006-10-17 Xerox Corporation Arylamine processes
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
JP2008538576A (ja) * 2005-04-22 2008-10-30 ワイス クロマンおよびクロメン誘導体およびその使用
CN101316821A (zh) * 2005-09-30 2008-12-03 詹森药业有限公司 作为rxr激动剂用于治疗异常脂肪血症、高胆固醇血症和糖尿病的二氢-[1h]-喹啉-2-酮衍生物
WO2010135524A1 (en) 2009-05-22 2010-11-25 Exelixis, Inc. Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
MX2011012584A (es) 2009-05-26 2012-02-21 Exelixis Inc Benzoxazepinas como inhibidores de pi3k/m tor, metodos para su uso y fabricación.
HUE034911T2 (hu) 2009-07-27 2018-03-28 Gilead Sciences Inc Fúzionált heterociklusos vegyületek mint ioncsatorna modulátorok
EP2588197B1 (en) 2010-07-02 2014-11-05 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
EP2611908A4 (en) * 2010-09-01 2014-04-02 Univ California Cell culture screen for agents that control adipogenesis and myofibroblast differentiation
WO2012154760A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused heterocyclic compounds as sodium channel modulators
WO2012153775A1 (ja) 2011-05-10 2012-11-15 国立大学法人神戸大学 Ras機能阻害作用を有するチオキソチアゾリジン誘導体
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
NO3175985T3 (cg-RX-API-DMAC7.html) 2011-07-01 2018-04-28
US10766927B2 (en) 2012-11-25 2020-09-08 The Regents Of The University Of California Peptides that stimulate subcutaneous adipogenesis
US10844102B2 (en) 2014-05-28 2020-11-24 The Regents Of The University Of California Peptides, compositions, and methods for stimulating subcutaneous adipogenesis
MX2020010999A (es) 2018-04-18 2021-01-20 Constellation Pharmaceuticals Inc Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos.
EP3797108B1 (en) 2018-05-21 2022-07-20 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
PE20220562A1 (es) 2019-07-24 2022-04-13 Constellation Pharmaceuticals Inc Formas cristalinas de 7-cloro-2-(4-(3-metoxiazetidin-1-il)ciclohexil)-2,4-dimetil-n-((6-metil-4-(metiltio)-2-oxo-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioxol-5-carboxamida

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051842A (en) * 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) * 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
JPS5538359A (en) 1978-09-12 1980-03-17 Hamari Yakuhin Kogyo Kk Preparation of 2-(3-benzoylphenyl)-propionic acid
US4383529A (en) * 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US4713244A (en) * 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
CA1325222C (en) 1985-08-23 1993-12-14 Lederle (Japan), Ltd. Process for producing 4-biphenylylacetic acid
DE3874257T2 (de) * 1987-03-11 1993-02-11 Kanegafuchi Chemical Ind Hydroxystyren-derivate.
US5330998A (en) * 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
US5223522A (en) * 1988-03-08 1993-06-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
IE940525L (en) 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
EP0595868B1 (en) * 1991-07-22 1998-11-25 Pfizer Inc. Process for the preparation of (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl]bromobenzene
DE69333894D1 (de) 1992-04-22 2005-12-01 Ligand Pharm Inc Verbindungen mit Retinoid x rezeptorselektivität
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
WO1994012880A2 (en) 1992-11-25 1994-06-09 La Jolla Cancer Research Foundation Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
ES2130597T3 (es) * 1994-02-17 1999-07-01 American Home Prod Derivados de bifenilo sustituido como inhibidores de la fosfodiesterasa.
US5691376A (en) * 1994-02-17 1997-11-25 American Home Products Corporation Substituted biphenyl derivatives
US5520752A (en) * 1994-06-20 1996-05-28 The United States Of America As Represented By The Secretary Of The Army Composite solders
JPH09136877A (ja) 1995-06-16 1997-05-27 Takeda Chem Ind Ltd 複素環化合物、その製造法及び用途
CA2223489A1 (en) 1995-07-17 1997-02-06 Joseph A. Fontana Method for treating cancer using ahpn
WO1997027191A1 (en) 1996-06-19 1997-07-31 Dr. Reddy's Research Foundation Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
US6127415A (en) * 1996-07-08 2000-10-03 Galderma Research & Development, S.N.C. Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
CA2300813A1 (en) 1997-08-21 1999-03-04 Hiroyuki Odaka Anti-inflammatory agent
EP1048659A4 (en) 1997-11-12 2002-11-20 Inst Med Molecular Design Inc Retinoid receptor Antagonist
US6235996B1 (en) * 1998-01-28 2001-05-22 International Business Machines Corporation Interconnection structure and process module assembly and rework
US6262044B1 (en) * 1998-03-12 2001-07-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPASES)
US6331633B1 (en) 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
IL141456A0 (en) 1998-08-21 2002-03-10 Viropharma Inc Rhodanine derivatives and pharmaceutical compositions containing the same
WO2000018748A1 (en) 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU3111700A (en) 1998-12-04 2000-06-19 Structural Bioinformatics Inc. Methods and compositions for treating inflammatory diseases utilizing inhibitorsof tumor necrosis factor activity
AU3958200A (en) 1999-04-20 2000-11-02 Novo Nordisk A/S New compounds, their preparation and use
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
CN1384825A (zh) * 1999-08-31 2002-12-11 马克西亚药品公司 亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用
PT1142885E (pt) 1999-11-12 2007-02-28 Fujimoto Brothers Co Ltd Derivados de 2-(n-cianoimino)tiazolidin-4-ona
FR2812876B1 (fr) * 2000-08-08 2002-09-27 Galderma Res & Dev Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques
BR0207846A (pt) * 2001-03-07 2005-09-13 Incyte San Diego Inc Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas
JP2004523571A (ja) 2001-03-08 2004-08-05 マキシア・ファーマシューティカルズ・インコーポレイテッド Rxr活性化分子
AU2002258550B2 (en) 2001-03-14 2006-04-27 Eli Lilly And Company Retinoid X receptor modulators
JP4590158B2 (ja) 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド グルコース再吸収阻害剤およびレチノイド−x受容体モジュレーターを含んで成る併用療法
EP1421061A4 (en) * 2001-08-17 2004-12-22 Incyte San Diego Inc OXIME DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA AND HYPERCHOLESTEROLEMIA
JP2005513026A (ja) * 2001-11-15 2005-05-12 インサイト サン ディエゴ インコーポレイテッド 高コレステロール血症、異脂肪血症および他の代謝障害;癌、および他の疾患を治療するn−置換複素環
TW200304375A (en) * 2001-12-06 2003-10-01 Maxia Pharmaceuticals Inc 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
US7196108B2 (en) 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US20050014767A1 (en) * 2003-01-29 2005-01-20 Magnus Pfahl Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
BRPI0409501A (pt) * 2003-04-18 2006-04-18 Incyte San Diego Inc compostos isocromanos substituìdos para o tratamento de desordens metabólicas, de cáncer e de outras doenças

Similar Documents

Publication Publication Date Title
KR101179087B1 (ko) 인간 단백질 티로신 포스파타아제 억제제 및 이용 방법
US8268867B2 (en) 1,3-dioxane carboxylic acids
JP2007523905A5 (cg-RX-API-DMAC7.html)
US5599826A (en) Thiazolidinediones and drugs containing them
JP2005530705A5 (cg-RX-API-DMAC7.html)
JP2009542659A5 (cg-RX-API-DMAC7.html)
JPH10194970A (ja) 置換チアゾリジンジオン誘導体を含む抗高脂血剤
CN1131391A (zh) 噻唑烷二酮衍生物及相关的抗高血糖药物在治疗患有非胰岛素依赖性糖尿病危险病症中的应用
MX2009000290A (es) Inhibidores de proteina tirosina fosfatasa humana y metodos de uso.
JP2005525371A (ja) 糖尿病および他の疾患を治療するための二環式複素環
KR20080034436A (ko) 암 치료에 사용되는 티아졸 유도체 및 유사체
RU2004129285A (ru) Производные тиазола в качестве антагонистов рецептора npy
RU2004129752A (ru) Гетероциклические амидные промзводные для лечения диабета и других заболеваний
JP2005526732A5 (cg-RX-API-DMAC7.html)
JP2013507397A5 (cg-RX-API-DMAC7.html)
US20030166697A1 (en) Heterocyclic compounds
JP2008214305A (ja) 置換アミン誘導体及びこれを有効成分とする医薬組成物
JP2013500961A (ja) グルコキナーゼ(gk)アクチベーターとしての置換ベンズアミド誘導体
RU2435763C2 (ru) Ингибиторы тирозинфосфатазы белка человека и способы применения
RU2005141516A (ru) Производные анилина
JP3893166B2 (ja) ベンゾフラン誘導体およびそれを含んでなる医薬組成物
RU2006102866A (ru) Тиазолзамещенные индолилпроизводные и их применение в качестве модуляторов ppar
TH79774A (th) ไบไซคลิคเฮเทอโรไซเคิลสำหรับการรักษาโรคเบาหวาน และโรคอื่น ๆ
HK1021326A (en) Composition for use in the treatment and prevention of hyperuricemia
MX2008008670A (en) 1,3-dioxane carboxylic acids